High-Risk Medicines in Community Pharmacy: Valproate, Methotrexate and Other Priority Drugs
A safety-focused course on managing high-risk medicines in community pharmacy, aligned with NHS England PQS audit requirements and national guidance. Covers valproate Pregnancy Prevention Programme (PPP) obligations, methotrexate weekly-dosing safety, and monitoring requirements for lithium, amiodarone and phenobarbital — with practical tools for audits, documentation and prescriber liaison.
Audio overview of this course — great for commuting or a quick preview 🎧
Some medicines are capable of causing serious, life-altering harm when something goes wrong — a wrong dose, a missed safety check, a patient who never received critical information. These are high-risk medicines: drugs where the difference between therapeutic benefit and catastrophic harm is narrow, and where community pharmacy's role in preventing that harm is both clearly defined and regularly audited.
This course focuses on the five medicines at the heart of NHS England and national pharmacy quality audit requirements: valproate, methotrexate, lithium, amiodarone and phenobarbital. It gives community pharmacy teams a practical, safety-centred foundation in what makes these medicines dangerous, what pharmacy teams are required to do at every dispensing episode, and how to embed robust safety processes — including valproate Pregnancy Prevention Programme (PPP) obligations — into everyday practice.
What you'll learn
- ✓Why valproate, methotrexate, lithium, amiodarone and phenobarbital are classified as high-risk medicines
- ✓Valproate PPP requirements: card and guide provision, contraception discussion, annual specialist review and when to refer
- ✓Methotrexate weekly-dosing safety: preventing daily dosing errors, toxicity signs, folic acid and interaction checks
- ✓Monitoring requirements and toxicity signs for lithium, amiodarone and phenobarbital
- ✓Key findings from NHS England PQS and national valproate clinical audits — and what they mean for practice
- ✓How to plan and run local high-risk medicine audits and record findings for future dispensing episodes
- ✓When and how to liaise with GPs and specialists when PPP conditions or safety requirements appear unmet
- ✓Practical tools: PPP dispensing checklist, methotrexate counselling checklist and high-risk medicines audit template
"Valproate is contraindicated in girls and women of childbearing potential unless the conditions of the Pregnancy Prevention Programme are met." — MHRA Drug Safety Update
Aligned with current standards
This course is aligned with NHS England Community Pharmacy PQS valproate and high-risk medicines audit reports, the 2022/23 CPCF national valproate clinical audit requirements, MHRA Pregnancy Prevention Programme guidance, PSNC/CPE PQS valproate briefing and decision tree, NHS Scotland community pharmacy methotrexate high-risk medicine tool, and shared-care protocol frameworks for methotrexate.
👤 Who this is for
Community pharmacists, pharmacy technicians and dispensing staff in England, Scotland and Wales who regularly handle high-risk medicines and need to embed safe processes into everyday practice. Particularly relevant for pharmacies subject to NHS England PQS valproate audit obligations and community pharmacy contractual framework (CPCF) national valproate clinical audit requirements.
⚠️ Guidance evolves — always verify current requirements. Valproate PPP requirements, PQS audit standards and high-risk medicines guidance are actively updated by MHRA, NHS England and devolved health bodies. This course reflects published guidance at time of writing; always check the most recent MHRA, NHS England, CPE and local shared-care documents before making clinical decisions or completing audit submissions. Content does not constitute prescribing advice.
Course Curriculum
More in this category
Respiratory Medicines Optimisation & Inhaler Technique in Community Pharmacy
A practical, service-oriented course for community pharmacists, pharmacy technicians and trained support staff in Great Britain. Covers the burden of asthma and COPD, inhaler device technique for pMDI, DPI and spacers, running structured inhaler check-up services, medicines optimisation and adherence, and how to embed respiratory quality improvement into everyday pharmacy practice.
This course includes
- 📚 5 modules · 16 lessons
- ⏱ 2h 30m self-paced learning
- 🎧 Audio course introduction
- 📥 3 downloadable templates & checklists
- 📝 Knowledge assessment quiz
- 🔁 Unlimited quiz re-attempts
- 🏆 Verified certificate on completion
- ♾️ Lifetime access to content
Downloadable templates
- Valproate PPP Dispensing Checklist
- Methotrexate Counselling Checklist
- High-Risk Medicines Audit Template
Templates unlock after enrolment
Standards & currency
Written by UK pharmacy experts. Always verify against current official guidance before clinical use.
Certificate of Achievement
Complete this course and earn a personalised, printable certificate — with your name, course title and a unique certificate number. Suitable as CPD evidence for GPhC revalidation and GPhC inspection records.